Black Bird Biotech, Inc.
BBBT
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -69.77% | 74.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -69.77% | 74.32% | |||
| Cost of Revenue | -57.63% | -28.92% | |||
| Gross Profit | -80.00% | 877.78% | |||
| SG&A Expenses | -88.84% | 24.41% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -86.22% | 19.07% | |||
| Operating Income | 88.47% | -14.13% | |||
| Income Before Tax | 33.40% | 26.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 33.40% | 26.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.40% | 26.19% | |||
| EBIT | 88.47% | -14.13% | |||
| EBITDA | 328.57% | -123.95% | |||
| EPS Basic | 66.67% | 50.00% | |||
| Normalized Basic EPS | 50.00% | 50.00% | |||
| EPS Diluted | 66.67% | 50.00% | |||
| Normalized Diluted EPS | 100.00% | 75.00% | |||
| Average Basic Shares Outstanding | 129.30% | 46.66% | |||
| Average Diluted Shares Outstanding | 74.91% | 153.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||